MPLT
MapLight Therapeutics, Inc. Common Stock
NASDAQ: MPLT · HEALTHCARE · BIOTECHNOLOGY
$30.70
-3.67% today
Updated 2026-05-01
Market cap
$1.30B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-18.56
Dividend yield
—
52W range
$12 – $33
Volume
0.3M
MapLight Therapeutics, Inc. Common Stock (MPLT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-56.20%
ROA
-34.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | — | $-30.02M | — | — | — |
| 2023 | — | $-55.71M | — | — | — |
| 2024 | — | $-77.58M | — | — | — |
| 2025 | $0.00 | $-161.15M | — | — | — |